Advertisement
U.S. markets open in 3 hours 50 minutes
Advertisement

Rubius Therapeutics, Inc. (RUBY)

Other OTC - Other OTC Delayed Price. Currency in USD
Visitors trend2W10W9M
0.0187+0.0006 (+3.31%)
At close: 03:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close0.0181
Open0.0181
Bid0.0000 x 1200
Ask0.0000 x 800
Day's Range0.0181 - 0.0187
52 Week Range0.0032 - 0.4200
Volume42,368
Avg. Volume63,782
Market Cap1.692M
Beta (5Y Monthly)2.23
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for RUBY

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Rubius Therapeutics, Inc.
    Daily – Vickers Top Buyers & Sellers for 04/25/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    2 years agoArgus Research
View more

  • We're sorry we weren't able to find anything about this topic.